St Germain D J CO Inc Taysha Gene Therapies, Inc. Transaction History
St Germain D J CO Inc
- $2.22 Billion
- Q2 2025
A detailed history of St Germain D J CO Inc transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, St Germain D J CO Inc holds 5,300 shares of TSHA stock, worth $13,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,300Holding current value
$13,727% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TSHA
# of Institutions
126Shares Held
151MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$51.8 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$48.7 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$43.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$30.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$28.2 Million0.31% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $125M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...